Takotsubo Cardiomyopathy Vs HOCM

Takotsubo Cardiomyopathy vs Obstructive Hypertrophic Cardiomyopathy (HOCM)

Takotsubo Cardiomyopathy Vs HOCM

Takotsubo cardiomyopathy, also known as stress-induced or “broken heart” cardiomyopathy, typically occurs after intense emotional or physical stress leading to a surge in catecholamines. It causes transient left ventricular dysfunction, most characteristically apical ballooning with basal hyperkinesis on echocardiography. The left ventricle usually has normal wall thickness, and any left ventricular outflow tract (LVOT) obstruction, if present, is mild or transient. Coronary angiography reveals normal coronary arteries, and left ventricular function generally recovers within days to weeks. On ECG, Takotsubo may mimic acute myocardial infarction with ST-segment elevation, deep T-wave inversions, and QT prolongation. Prognosis is usually favorable once the stress trigger is resolved.

In contrast, obstructive hypertrophic cardiomyopathy (HOCM) is a chronic, genetic disorder caused by sarcomeric gene mutations leading to asymmetric septal hypertrophy. This thickening produces a fixed or dynamic LVOT obstruction due to systolic anterior motion (SAM) of the mitral valve. Echocardiography shows a hypertrophied basal septum, a resting or provoked LVOT gradient greater than 30 mmHg, and dynamic mitral regurgitation. The ejection fraction is often normal or hyperdynamic. ECG findings typically include voltage criteria for left ventricular hypertrophy and deep, narrow Q waves in inferior and lateral leads. Unlike Takotsubo, the structural changes in HOCM are permanent and may predispose to arrhythmias and sudden cardiac death.

In summary, Takotsubo represents a transient “stunned” ventricle after stress with reversible apical ballooning, while obstructive HCM represents a genetically “thickened” heart with persistent LVOT obstruction. In simple terms: Takotsubo is the broken heart; HOCM is the thick heart.

Comments

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

Dr. Usman's Cardiology Notes

Search This Blog